Richard Beckman | Chief Medical Officer
ReNeuron Group Plc

Richard Beckman, Chief Medical Officer, ReNeuron Group Plc

Dr Richard Beckman was appointed Chief Medical Officer in April 2018. Prior to joining ReNeuron, Dr Beckman was the Chief Medical Officer of several innovative biotech and device firms, including Clearside, Ophthotech and Neurotech. Prior to that, he had leadership roles at Alcon, Lux Bio, Becton Dickinson and Allergan. Dr Beckman received his MD from the University of Michigan, completed a residency in ophthalmology at Henry Ford Hospital, and a glaucoma fellowship at the Mass. Eye and Ear Infirmary/Harvard University. Prior to joining the industry, he practised in academic medicine for three years at Cornell University Medical College and was in private practice for 10 years.


Day 1: Wednesday 19th May 2021 - Cell Therapy @ 14:30

Roundtable: neurological & ophthalmic applications for ATMPs

last published: 10/May/21 08:45 GMT

back to speakers